The message in the air: Hydrogen sulfide metabolism in chronic respiratory diseases

被引:70
作者
Chen, Yahong [2 ]
Wang, Rui [1 ]
机构
[1] Lakehead Univ, Off VP Res, Dept Biol, Thunder Bay, ON P7B 5E1, Canada
[2] Peking Univ, Hosp 3, Resp Dept, Beijing 100871, Peoples R China
关键词
Hydrogen sulfide; Asthma; Chronic respiratory diseases; 1-MEDIATED NEUROGENIC INFLAMMATION; EXHALED NITRIC-OXIDE; HYPERBARIC-OXYGEN; GLOBAL STRATEGY; CARBON-MONOXIDE; BREATH; H2S; MECHANISMS; PREVENTION; BIOMARKERS;
D O I
10.1016/j.resp.2012.03.009
中图分类号
Q4 [生理学];
学科分类号
071003 [生理学];
摘要
Hydrogen sulfide (H2S) is an important gasotransmitter in the mammalian respiratory system. The enzymes that produce H2S mainly cystathionine-beta-synthase and cystathionine-gamma-lyase - are expressed in pulmonary and airway tissues. Endogenous H2S participates in the regulation of the respiratory system's physiological functions and pathophysiological alterations, such as chronic obstructive pulmonary disease, asthma, pulmonary fibrosis and hypoxia-induced pulmonary hypertension, to name a few. The cellular targets of H2S in the respiratory system are diverse, including airway smooth muscle cells, epithelial cells, fibroblasts, and pulmonary artery smooth muscle cells. H2S also regulates respiratory functions such as airway constriction, pulmonary circulation, cell proliferation or apoptosis, fibrosis, oxidative stress, and neurogenic inflammation. Cross-talk between H2S and other gasotransmitters also affects the net outcome of lung function. The metabolism of H2S in the lungs and airway may serve as a biomarker for specific respiratory diseases. It is expected that strategies targeted at the metabolism and function of H2S will prove useful for the prevention and treatment of selective chronic respiratory diseases. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:130 / 138
页数:9
相关论文
共 77 条
[1]
Hydrogen sulfide promotes transient receptor potential vanilloid 1-mediated neurogenic inflammation in polymicrobial sepsis [J].
Ang, Seah-Fang ;
Moochhala, Shabbir M. ;
Bhatia, Madhav .
CRITICAL CARE MEDICINE, 2010, 38 (02) :619-628
[2]
ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[3]
Medical therapy for pulmonary arterial hypertension - Updated ACCP evidence-based clinical practice guidelines [J].
Badesch, David B. ;
Abman, Steven H. ;
Simonneau, Gerald ;
Rubin, Lewis J. ;
McLaughlin, Vallerie V. .
CHEST, 2007, 131 (06) :1917-1928
[4]
Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis [J].
Barker, M ;
Hengst, M ;
Schmid, J ;
Buers, HJ ;
Mittermaier, B ;
Klemp, D ;
Koppman, R .
EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (05) :929-936
[5]
Barnes Peter J, 2005, Proc Am Thorac Soc, V2, P334, DOI 10.1513/pats.200504-024SR
[6]
Exhaled Nitric Oxide in Pulmonary Diseases A Comprehensive Review [J].
Barnes, Peter J. ;
Dweik, Raed A. ;
Gelb, Arthur F. ;
Gibson, Peter G. ;
George, Steven C. ;
Grasemann, Hartmut ;
Pavord, Ian D. ;
Ratjen, Felix ;
Silkoff, Philip E. ;
Taylor, D. Robin ;
Zamel, Noe .
CHEST, 2010, 138 (03) :682-692
[7]
Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells [J].
Baskar, Rajamanickam ;
Li, Ling ;
Moore, Philip Keith .
FASEB JOURNAL, 2007, 21 (01) :247-255
[8]
Global strategy for asthma management and prevention: GINA executive summary [J].
Bateman, E. D. ;
Hurd, S. S. ;
Barnes, P. J. ;
Bousquet, J. ;
Drazen, J. M. ;
FitzGerald, M. ;
Gibson, P. ;
Ohta, K. ;
O'Byrne, P. ;
Pedersen, S. E. ;
Pizzichini, E. ;
Sullivan, S. D. ;
Wenzel, S. E. ;
Zar, H. J. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (01) :143-178
[9]
A CRITICAL-REVIEW OF THE LITERATURE ON HYDROGEN-SULFIDE TOXICITY [J].
BEAUCHAMP, RO ;
BUS, JS ;
POPP, JA ;
BOREIKO, CJ ;
ANDJELKOVICH, DA .
CRC CRITICAL REVIEWS IN TOXICOLOGY, 1984, 13 (01) :25-97
[10]
Belley Richard, 2005, CJEM, V7, P257